Nonopioid Analgesia After Labral Surgery

Description

This is a randomized, single blinded, standard of care controlled clinical trial. This project aims to compare postoperative pain control in patients in two treatment arms of rotator cuff repair: a treatment group given a nonopioid pain control regimen, and a standard of care control group given standard opioid pain control regimen

Conditions

Narcotic Use

Talk to us

Study Overview

On this page

Study Details

Study overview

This is a randomized, single blinded, standard of care controlled clinical trial. This project aims to compare postoperative pain control in patients in two treatment arms of rotator cuff repair: a treatment group given a nonopioid pain control regimen, and a standard of care control group given standard opioid pain control regimen

Traditional vs. Nonopioid Analgesia After Labral Surgery

Nonopioid Analgesia After Labral Surgery

Condition
Narcotic Use
Intervention / Treatment

-

Contacts and Locations

Detroit

Henry Ford Health System, Detroit, Michigan, United States, 48202

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * All adult patients over age 18 and scheduled for a primary or revision labral surgery
  • * Exclusion criteria will include patients with a medical history of known allergies or intolerance to allergies or intolerance to Celebrex, Tylenol, Neurontin, dexamethasone, tramadol, substantial alcohol or drug abuse, and pregnancy, history of narcotics within 6 months of surgery, renal impairment, peptic ulcer disease, GI bleeding. Secondary exclusion criterion is an intact rotator cuff

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Henry Ford Health System,

Toufic R Jildeh, MD, PRINCIPAL_INVESTIGATOR, Henry Ford Health System

Study Record Dates

2020-05-20